Stocksigma LogoStocksigma Logo

Supriya Lifescience Reports Q2 Results and Appoints Mangesh Vaze as COO

Supriya Lifescience reported standalone revenue from operations of ₹2,062.97 million for the quarter ended 30th Sep'26, up 3.2% YoY from ₹1,998.33 million

Supriya Lifescience Reports Q2 Results and Appoints Mangesh Vaze as COO

Supriya Lifescience Ltd · Change in Management · 06 Nov 2026, 6:46 pm

Supriya Lifescience Reports Q2 Results and Appoints Mangesh Vaze as COO Supriya Lifescience reported standalone revenue from operations of ₹2,062.97 million for the quarter ended 30th Sep'26, up 3.2% YoY from ₹1,998.33 million and 8.7% QoQ. Net profit declined 42.0% YoY to ₹292.50 million versus ₹504.27 million in the year-ago period, but rose 21.7% QoQ from ₹240.43 million. H1 FY27 revenue reached ₹3,960.44 million with a net profit of ₹532.93 million. Additionally, the Board appointed Mangesh Vaze as Chief Operating Officer and Senior Management Personnel, effective 6th Nov'26.

Original exchange filing (PDF)

More announcements from Supriya Lifescience Ltd

All Supriya Lifescience Ltd announcements